Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Drugs
|
May 5, 2022
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer
Ronan Flippot, Anna Patrikidou, Mihaela Aldea, et al.
Molecular Cancer Therapeutics
|
October 27, 2019
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
Amin H Nassar, Lana Hamieh, Kathryn P Gray, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2026
Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMET
Sylvie Negrier, Loïc Mourey, Cécile Dalban, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2025
High circulating IL-6/IL-8 is associated with intratumoral myeloid contexture and poor outcomes in advanced renal cell carcinoma patients treated with PD-1 blockade
Lucia Carril-Ajuria, Ronan Flippot, Marie Naigeon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 17, 2023
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study
Edwige Baudry, Natacha Naoun, Edouard Auclin, et al.
World Journal of Urology
|
June 2, 2021
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers
Simone Albisinni, Marco Moschini, Ettore Di Trapani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
Clara Helal, Cédric Pobel, Arnaud Bayle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 21, 2019
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases
Ronan Flippot, Pamela Biondani, Edouard Auclin, et al.
European Urology
|
June 9, 2021
Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial
Jean Courcier, Cécile Dalban, Brigitte Laguerre, et al.
Journal for Immunotherapy of Cancer
|
November 7, 2023
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma
Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Drugs
|
May 5, 2022
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer
Ronan Flippot, Anna Patrikidou, Mihaela Aldea, et al.
Molecular Cancer Therapeutics
|
October 27, 2019
Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
Amin H Nassar, Lana Hamieh, Kathryn P Gray, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 7, 2026
Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMET
Sylvie Negrier, Loïc Mourey, Cécile Dalban, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2025
High circulating IL-6/IL-8 is associated with intratumoral myeloid contexture and poor outcomes in advanced renal cell carcinoma patients treated with PD-1 blockade
Lucia Carril-Ajuria, Ronan Flippot, Marie Naigeon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 17, 2023
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study
Edwige Baudry, Natacha Naoun, Edouard Auclin, et al.
World Journal of Urology
|
June 2, 2021
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers
Simone Albisinni, Marco Moschini, Ettore Di Trapani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 28, 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer
Clara Helal, Cédric Pobel, Arnaud Bayle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 21, 2019
Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases
Ronan Flippot, Pamela Biondani, Edouard Auclin, et al.
European Urology
|
June 9, 2021
Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial
Jean Courcier, Cécile Dalban, Brigitte Laguerre, et al.
Journal for Immunotherapy of Cancer
|
November 7, 2023
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma
Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, et al.
Page
of 8